Fri, June 18, 2021
Thu, June 17, 2021
Wed, June 16, 2021
Tue, June 15, 2021

Raghuram Selvaraju Maintained (ACRS) at Strong Buy with Increased Target to $50 on, Jun 16th, 2021

Raghuram Selvaraju of HC Wainwright & Co., Maintained "Aclaris Therapeutics, Inc." (ACRS) at Strong Buy with Increased Target from $40 to $50 on, Jun 16th, 2021.

Raghuram has made no other calls on ACRS in the last 4 months.



There are 2 other peers that have a rating on ACRS. Out of the 2 peers that are also analyzing ACRS, 0 agree with Raghuram's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Raghuram


  • Christopher Raymond of "Piper Sandler" Initiated at Buy and Held Target at $30 on, Tuesday, June 15th, 2021
  • Thomas Smith of "SVB Leerink" Maintained at Buy with Increased Target to $26 on, Thursday, March 4th, 2021